[Should we block interleukin-1 in atherothrombosis?].
Antonino
A
Nicoletti
Giuseppina
G
Caligiuri
Benoit
B
Ho-Tin-Noé
Jean-Baptiste
JB
Michel
D000906:Antibodies / Q000627:therapeutic use*; D017700:Embolism, Cholesterol / Q000150:complications / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000706:statistics & numerical data*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors* / Q000276:immunology; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000706:statistics & numerical data / Q000639:trends; D058226:Plaque, Atherosclerotic / Q000150:complications / Q000628:therapy*; D013927:Thrombosis / Q000150:complications / Q000628:therapy*
D000906:Antibodies; D007375:Interleukin-1